Patents by Inventor Jens Pahnke

Jens Pahnke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosing or prediagnosing a beta-amyloidopathy or an alpha-synucleopathy
    Patent number: 9370523
    Abstract: The invention relates to a method for the diagnosis or prediagnosis of a ?-amyloidopathy or an ?-synucleopathy accompanied by a cerebral protein deposit and a reduced activity of the cerebral ABCC1-transporter, or for determining the risk of a proband suffering from such an illness, the proband already having accumulated substances transported by the cerebral ABCC1 transporter.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: June 21, 2016
    Assignee: Immungenetics AG
    Inventor: Jens Pahnke
  • 2-(R2-THIO)-10-[3-(4-R1-PIPERAZIN-1-YL)PROPYL]-10H-PHENOTHIAZINES FOR TREATING A B-AMYLOIDOPATHY OR AN A-SYNUCLEOPATHY, AND METHOD FOR THE DIAGNOSIS OR PREDIAGNOSIS THEREOF
    Publication number: 20150374711
    Abstract: The invention relates to 2-(R2-thio)-10-[3-(4-R1-piperazin-1-yl)propyl]- 10H-phenothiazine according to general formula I, for treating a ?-amyloidopathy or an ?-synucleinopathy accompanied by a cerebral protein deposit and a reduced activity of the cerebral ABCC1-transporter. The invention also relates to a method for the diagnosis or prediagnosis of a ?-amyloidopathy or an ?-synucleopathy accompanied by a cerebral protein deposit and a reduced activity of the cerebral ABCC1-transporter, or for determining the risk of a proband suffering from such an illness, the proband already having accumulated substances transported by the cerebral ABCC1 transporter.
    Type: Application
    Filed: September 8, 2015
    Publication date: December 31, 2015
    Inventor: Jens Pahnke
  • Plant extracts for treating neurodegenerative diseases
    Patent number: 9198944
    Abstract: The invention relates to the use of ironwort extracts that can be obtained by means of extracting using water or water-alcohol solvents or mixtures thereof, for producing a formulation, and for treating or preventing neurodegenerative diseases.
    Type: Grant
    Filed: December 3, 2013
    Date of Patent: December 1, 2015
    Assignee: FINZELBERG GMBH & CO. KG
    Inventors: Bernd Walbroel, Björn Feistel, Jens Pahnke
  • METHOD FOR DIAGNOSING OR PREDIAGNOSING A BETA-AMYLOIDOPATHY OR AN ALPHA-SYNUCLEOPATHY
    Publication number: 20150024418
    Abstract: The invention relates to a method for the diagnosis or prediagnosis of a ?-amyloidopathy or an ?-synucleopathy accompanied by a cerebral protein deposit and a reduced activity of the cerebral ABCC1-transporter, or for determining the risk of a proband suffering from such an illness, the proband already having accumulated substances transported by the cerebral ABCC1 transporter.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 22, 2015
    Inventor: Jens Pahnke
  • PLANT EXTRACTS FOR TREATING NEURODEGENERATIVE DISEASES
    Publication number: 20140093591
    Abstract: The invention relates to the use of ironwort extracts that can be obtained by means of extracting using water or water-alcohol solvents or mixtures thereof, for producing a formulation, and for treating or preventing neurodegenerative diseases.
    Type: Application
    Filed: December 3, 2013
    Publication date: April 3, 2014
    Applicant: Finzelberg GmbH & Co. KG
    Inventors: Bernd Walbroel, Björn Feistel, Jens Pahnke
  • Plant extracts for treating neurodegenerative diseases
    Patent number: 8623427
    Abstract: The invention relates to the use of bedstraw extracts that can be obtained by means of extracting using water or water-alcohol solvents or mixtures thereof, for producing a formulation, and for treating or preventing neurodegenerative diseases.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: January 7, 2014
    Assignee: Finzelberg GmbH & Co. KG
    Inventors: Bernd Walbroel, Björn Feistel, Jens Pahnke
  • 2-(R2-THIO)-10-[3-(4-R1-PIPERAZIN-1-YL) PROPYL]-10H-PHENOTHIAZINE FOR TREATING A BETA-AMYLOIDOPATHY OR AN ALPHA-SYNUCLEOPATHY, AND METHOD FOR THE DIAGNOSIS OR PREDIAGNOSIS THEREOF
    Publication number: 20130184268
    Abstract: The invention relates to 2-(R2-thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine according to general formula I, for treating a ?-amyloidopathy or an ?-synucleinopathy accompanied by a cerebral protein deposit and a reduced activity of the cerebral ABCC1-transporter. The invention also relates to a method for the diagnosis or prediagnosis of a ?-amyloidopathy or an ?-synucleopathy accompanied by a cerebral protein deposit and a reduced activity of the cerebral ABCC1-transporter, or for determining the risk of a proband suffering from such an illness, the proband already having accumulated substances transported by the cerebral ABCC1 transporter.
    Type: Application
    Filed: August 30, 2011
    Publication date: July 18, 2013
    Applicant: Immungenetics AG
    Inventor: Jens Pahnke
  • PLANT EXTRACTS FOR TREATING NEURODEGENERATIVE DISEASES
    Publication number: 20130022693
    Abstract: The invention relates to the use of bedstraw extracts that can be obtained by means of extracting using water or water-alcohol solvents or mixtures thereof, for producing a formulation, and for treating or preventing neurodegenerative diseases.
    Type: Application
    Filed: December 22, 2010
    Publication date: January 24, 2013
    Inventors: Bernd Walbroel, Björn Feistel, Jens Pahnke